Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that a new modular sterile filling system specifically tailored for process development, pilot scale and clinical supply, is now fully operational at its facility in Wasserburg, Germany.

The new system can deliver 500 to 50,000 units per batch, covering all the development phases of a product, and is optimised for small-batch production, offering an efficient solution for clinical development projects across rare disease pharmaceuticals, cell and gene therapies, and other advanced and emerging modalities with highly focused patient populations.